BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Expression data from PDGF driven mouse tumors

Dataset: Expression data from PDGF driven mouse tumors

Background Tumor heterogeneity is a major obstacle for finding effective treatment of Glioblastoma (GBM). Based on global expression...

Registered by ArrayExpress Uploader
View Dataset

Background Tumor heterogeneity is a major obstacle for finding effective treatment of Glioblastoma (GBM). Based on global expression analysis, GBM can be classified into distinct subtypes: Proneural, Neural, Classical and Mesenchymal. The signatures of these different tumor subtypes may reflect the phenotypes of cells giving rise to them. However, the experimental evidence connecting any specific subtype of GBM to particular cells of origin is lacking. In addition, it is unclear how different genetic alterations interact with cells of origin in determining tumor heterogeneity. This issue cannot be addressed by studying end-stage human tumors. Methodology/Principal Findings To address this issue, we used retroviruses to deliver transforming genetic lesions to glial progenitors in adult mouse brain. We compared the resulting tumors to human GBM. We found that different initiating genetic lesions gave rise to tumors with different growth rates. However all mouse tumors closely resembled the human Proneural GBM. Comparative analysis of these mouse tumors allowed us to identify a set of genes whose expression in humans with Proneural GBM correlates with survival. Conclusions/Significance This study offers insights into the relationship between adult glial progenitors and Proneural GBM, and allows us to identify molecular alterations that lead to more aggressive tumor growth. In addition, we present a new preclinical model that can be used to test treatments directed at a specific type of GBM in future studies. Gene expression profiling was performed on 20 tumors (12 Ptenf/f and 8 Ptenf/f; p53f/f) and 3 normal brains from mice. End stage tumors were used for expression array analysis. The platform used was Affymetrix GeneChip Mouse Genome 430A 2.0 Array. The microarray labeling, hybridization and quality controls were performed by following Affymetrix protocol.

Species:
mouse

Samples:
23

Source:
E-GEOD-29458

PubMed:
21625383

Updated:
Dec.12, 2014

Registered:
Nov.11, 2014


Factors: (via ArrayExpress)
Sample GENOTYPE ORGANISM PART
GSM729233 Ptenf/f Tumor
GSM729233 Ptenf/f Tumor
GSM729233 Ptenf/f Tumor
GSM729233 Ptenf/f Tumor
GSM729233 Ptenf/f Tumor
GSM729233 Ptenf/f Tumor
GSM729239 Ptenf/f; p53f/f Tumor
GSM729239 Ptenf/f; p53f/f Tumor
GSM729239 Ptenf/f; p53f/f Tumor
GSM729239 Ptenf/f; p53f/f Tumor
GSM729239 Ptenf/f; p53f/f Tumor
GSM729233 Ptenf/f Tumor
GSM729233 Ptenf/f Tumor
GSM729233 Ptenf/f Tumor
GSM729233 Ptenf/f Tumor
GSM729233 Ptenf/f Tumor
GSM729233 Ptenf/f Tumor
GSM729239 Ptenf/f; p53f/f Tumor
GSM729239 Ptenf/f; p53f/f Tumor
GSM729239 Ptenf/f; p53f/f Tumor
GSM729253 wild type Normal brain
GSM729253 wild type Normal brain
GSM729253 wild type Normal brain

Tags

  • brain
  • gbm
  • genome

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use